DrugDashboards

Market view

guaifenesin and dextromethorphan hydrobromide · Tablet, Extended Release

29 marketed package NDCs · 7 active manufacturers

Most dispensed: 10 mg/5mL; 100 mg/5mL · Syrup · #237 mL/bottle, plastic · 600 mg; 30 mg · Tablet, Extended Release · #2 blister packs/carton / 20 tablet, extended release in 1 blister pack · 600 mg; 30 mg · Tablet, Extended Release · #1 blister pack/carton / 20 tablet, extended release in 1 blister pack · 600 mg; 30 mg · Tablet, Extended Release · #1 pouch/carton / 2 tablet, extended release in 1 pouch

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

What changed in the last 90 days

Every detected change for guaifenesin and dextromethorphan hydrobromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mucinex DMSep 3, 2026
    Mfr exited
    A-S Medication Solutions · guaifenesin and dextromethorphan hydrobromide
  • Mucinex DMSep 3, 2026
    New product
    Select Consumer Group
  • Rite-Aid · guaifenesin and dextromethorphan hydrobromide
  • Mfr exited
    Reckitt Benckiser LLC · guaifenesin and dextromethorphan hydrobromide
  • Cvs Pharmacy, Inc · guaifenesin and dextromethorphan hydrobromide
  • Mfr exited
    A-S Medication Solutions · guaifenesin and dextromethorphan hydrobromide
  • Mucinex DMSep 2, 2026
    Mfr exited
    Sportpharm LLC · guaifenesin and dextromethorphan hydrobromide
  • Mucinex DMSep 2, 2026
    Mfr exited
    Select Consumer Group · guaifenesin and dextromethorphan hydrobromide
  • Mucinex DMSep 2, 2026
    Mfr exited
    Reckitt Benckiser LLC · guaifenesin and dextromethorphan hydrobromide
  • Guaifenesin DMSep 2, 2026
    Mfr exited
    PD-Rx Pharmaceuticals, Inc. · guaifenesin and dextromethorphan hydrobromide

Same drug class

Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Guaifenesin and dextromethorphan hydrobromide in shortage right now?
No. FDA does not currently list Guaifenesin and dextromethorphan hydrobromide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Guaifenesin and dextromethorphan hydrobromide?
13 companies have marketed Guaifenesin and dextromethorphan hydrobromide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Guaifenesin and dextromethorphan hydrobromide cost?
The typical pharmacy pays about $0.0231 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.